Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)-Reference-Cited by-同舟云学术

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Published:2018-06-14 Issue:4 Volume:13 Page:469-479
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Farolfi Alberto^ORCID,Petrone Micaela,Scarpi Emanuela,Gallà Valentina,Greco Filippo,Casanova Claudia,Longo Lucia,Cormio Gennaro,Orditura Michele,Bologna Alessandra,Zavallone Laura,Ventriglia Jole,Franzese Elisena,Loizzi Vera,Giardina Donatella,Pigozzi Eva,Cioffi Raffaella,Pignata Sandro,Giorda Giorgio,De Giorgi Ugo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s11523-018-0574-1/fulltext.html

Reference36 articles.

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

2. Karam A, Ledermann JA, Kim JW, et al. 5th ovarian Cancer consensus conference. In: Fifth Ovarian Cancer Consensus Conference of the gynecologic Cancer InterGroup: First-Line Interventions. Ann Oncol. 2017;28:711–7.

3. Perren TJ, Swart AM, Pfisterer J, et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011;365:2484–96.

4. Burger RA, Brady MF, Bookman MA, et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011;365:2473–83.

5. Oza AM, Cook AD, Pfisterer J, et al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015;16:928–36.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A predictive model for colorectal cancer complicated with intestinal obstruction based on specific inflammation score;BMC Cancer;2024-08-22

2. Probiotics alleviate paraneoplastic thrombocythemia of ovarian cancer: A randomized placebo-controlled trial;Journal of Functional Foods;2024-08

3. The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer;Clinical and Translational Oncology;2024-06-21

4. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line;Clinical and Translational Oncology;2024-06-10

5. Comparison of the effect between traditional conservation and nasointestinal tube placement in adhesive small bowel obstruction: A matched case-control study;Asian Journal of Surgery;2024-05